This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe
November 9–11, 2026
KoelnmesseCologne, Germany
Register
Menu
Register

Thomas Jaecklin
Chief Medical Officer at Gibela Therapeutics
Speaker

Profile

Innovative biotech drug developer, leading Mirum Pharmaceutical's first-in-class IBAT inhibitor programs up to successful approval, NodThera's clinical positioning of NLRP3 inhibitors and Gibela Therapeutics' fundraiser to develop a new liver target.

Agenda Sessions

  • Building a Clinical Strategy for Rare Disease Therapeutics

    , 10:30
    View Session

At this event

Prev
Next
Jeremy Levin
Executive Chairman
Ovid Therapeutics Inc

See Thomas at BIO-Europe

Register